Publication

An economic evaluation of the current measles vaccination program: a case study in Zhejiang Province, east China

Authored by:

Zeng Y, Leo M, Chen J et al.

Full Citation:

Zeng Y, Leo M, Chen J et al. 2019. An economic evaluation of the current measles vaccination program: a case study in Zhejiang Province, east China. Vaccine. 37(23).

View Publication

Additional key concepts from this publication:

Vaccines are among the most cost-effective health interventions available.

Key Evidence: An analysis of current measles vaccination program in the eastern Chinese province of Zhejiang (which provides 1 dose of measles-rubella vaccine at 8 months of age and 1 dose of MMR at 18 months) estimated that, for every dollar spent on immunization, the health system saves $6.06 in treatment costing, including the costs of treating complications and long-term sequelae, such as hearing loss.